Johnson & Johnson: all 3,718 studies

Page 21 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor Positron Emission Tomography (PET) Tracer 18F-JNJ-64413739CompletedNCT03088644Phase 1
• A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior AssessmentCompletedNCT03085108
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Japanese ParticipantsCompletedNCT03080987Phase 1
• A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy ParticipantsCompletedNCT03066687Phase 1
• Evaluation of Ablation Index and VISITAG™ (ABI-173)CompletedNCT03062046Not applicable
• Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)TerminatedNCT03059303Phase 1
• A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy SubjectsCompletedNCT03058419Phase 1
• Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese ParticipantsCompletedNCT03053024
• A Pharmacokinetic Study of MABp1 in Healthy VolunteersCompletedNCT03047317Phase 1
• Multiday Beach StudyCompletedNCT03041064Not applicable
• Tiara™ Transcatheter Mitral Valve Replacement StudyCompletedNCT03039855Not applicable
• FIND CAN Trial: "CF-172"CompletedNCT03033641Not applicable
• A First in Human Study to Assess the Safety, Tolerability and Immunogenicity of a Single Dose of a Trivalent Inactivated Poliovirus Vaccine Based on Sabin Strains (sIPV) Given Intramuscularly in Healthy AdultsCompletedNCT03032588Phase 1
• Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy VolunteersTerminatedNCT03032536Phase 1
• A Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy SubjectsCompletedNCT03025022Phase 1
• A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their Respective Reference Formulation in Healthy Adult ParticipantsCompletedNCT03023852Phase 1
• A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar DisorderCompletedNCT03017781
• Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)CompletedNCT03014544
• A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept FormulationsCompletedNCT03010059Phase 1
• A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healthy ParticipantsCompletedNCT03007693Phase 1
• Tracking Biologics Along the Silk RoadCompletedNCT03006198
• A Study to Characterize the Absorption, Metabolism, and Excretion of 14C-JNJ-53718678 After a Single Oral Dose in Healthy Male ParticipantsCompletedNCT03002779Phase 1
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male ParticipantsCompletedNCT03002025Phase 1
• Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction - Safety and Feasibility StudyCompletedNCT03000270Not applicable
• Smartphones to Improve Rivaroxaban ADHEREnce in Atrial FibrillationCompletedNCT02996435Phase 4
• Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo TabletsCompletedNCT02993237Phase 1
• Evaluation of a Multi-electrode Linear Type Catheter (D-1368-01-SI)CompletedNCT02991313Not applicable
• Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult ParticipantsCompletedNCT02984852Phase 1
• A Clinical Assessment of the Efficacy and Effects of Different Skincare Regimens on InfantsCompletedNCT02981056Not applicable
• Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month StudyCompletedNCT02980497Not applicable
• Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)TerminatedNCT02968901Phase 4
• A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's DiseaseCompletedNCT02968108Phase 1
• A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of OdalasvirCompletedNCT02961660Phase 1
• Evaluation of Sunscreens Under Actual Use ConditionsCompletedNCT02952235Not applicable
• Study to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076 in Healthy ParticipantsWithdrawnNCT02951845Phase 1
• A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Male SubjectsCompletedNCT02949206Phase 1
• A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy ParticipantsCompletedNCT02945020Phase 1
• A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-53718678 Administered as Oral Concept Formulation Compared to the Current Oral Solution and to Assess the Effect of Food on the Pharmacokinetics of Oral Concept FormulationCompletedNCT02945007Phase 1
• A Study in Healthy Participants to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and PlasmaCompletedNCT02933762Phase 1
• A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-56136379 in Healthy Japanese Adult ParticipantsCompletedNCT02933580Phase 1
• Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)CompletedNCT02932774Phase 4
• A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446 in Healthy Male and Female ParticipantsCompletedNCT02930694Phase 1
• Assessment of Blood Glucose Monitoring Devices With New Insight FeaturesCompletedNCT02929654Not applicable
• Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)CompletedNCT02926456
• A Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Vaccinations of Ad26.RSV.preF One Year Apart in Adults Aged 60 Years and Older in Stable HealthCompletedNCT02926430Phase 1
• A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)CompletedNCT02924766Phase 1
• Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy SubjectsCompletedNCT02923583Phase 1
• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus ErythematosusWithdrawnNCT02920424Phase 1
• Memory Gel and Shape Combined CohortActive, not recruitingNCT02919592Not applicable
• A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive DisorderCompletedNCT02919579Phase 1
• A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell TransplantationCompletedNCT02918331Phase 1
• Safety and Feasibility of the Shockwave Lithoplasty® System for the Treatment of Peripheral Vascular StenosisCompletedNCT02911623Not applicable
• A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced CancersActive, not recruitingNCT02908906Phase 1/2
• A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate CancerWithdrawnNCT02906605Phase 2
• A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)WithdrawnNCT02905201
• A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive DisorderCompletedNCT02902601Phase 1
• Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)WithdrawnNCT02895815Phase 2
• A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological MalignancyTerminatedNCT02895529Phase 4
• A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335CompletedNCT02894905Phase 1
• A Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of Odalasvir Administered as a Single Dose Tablet Under Fed Conditions in Healthy ParticipantsCompletedNCT02889367Phase 1
• A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872CompletedNCT02888327Phase 1
• To Evaluate the Effects of Odalasvir and AL-335 With Simeprevir on the Single-Dose Pharmacokinetics of Ethinylestradiol and Drospirenone in Healthy Female ParticipantsCompletedNCT02885454Phase 1
• Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy SubjectsCompletedNCT02882425Phase 1
• Study to Assess the Bioequivalence of Ibrutinib 140 Milligram (mg) Tablet to 140 mg IMBRUVICA CapsuleCompletedNCT02877225Phase 1
• A Study to Assess the PK of AL-794 Formulations in Healthy SubjectsCompletedNCT02877160Phase 1
• Evaluation of the Functional Remission Occurrence and Predictive Factors in SchizophreniaCompletedNCT02874560
• A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted ParticipantsCompletedNCT02865668Phase 1
• Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Type 2 Diabetes Mellitus (T2DM)TerminatedNCT02862431Phase 1
• Safety, Tolerability, Pharmacokinetic and Absolute Bioavailability Study of JNJ-63623872 Administered as an Intravenous Infusion and a 600-Milligram (mg) Oral Dose in Healthy AdultsCompletedNCT02860806Phase 1
• A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy AdultsCompletedNCT02860650Phase 1
• Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese SubjectsCompletedNCT02857777Phase 1
• Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United StatesCompletedNCT02857764
• Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic TherapyCompletedNCT02852837Phase 1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274CompletedNCT02852395Phase 1
• A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted ParticipantsCompletedNCT02851212Phase 1
• A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted ParticipantsCompletedNCT02851095Phase 1
• Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered EsketamineCompletedNCT02846519Phase 1
• A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted ParticipantsCompletedNCT02846506Phase 1
• Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA CapsulesCompletedNCT02841150Phase 1
• 14022 ATTUNE Cementless RP Clinical Performance EvaluationActive, not recruitingNCT02839850Not applicable
• A Study to Assess the Effects of Age and Gender on the Pharmacokinetics of JNJ-42847922 in Healthy AdultsCompletedNCT02837692Phase 1
• Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese ParticipantsCompletedNCT02835508Phase 1
• Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy ParticipantsCompletedNCT02833831Phase 1
• Protected PCI StudyStatus unknownNCT02831881
• A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and ImplicationsCompletedNCT02830178
• A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage TumorsCompletedNCT02829099Phase 1
• An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)CompletedNCT02828046Phase 1
• Study to Investigate the Pharmacokinetic Interaction Between 2 Direct Acting Antiviral Agents Odalasvir and AL-335 and Between 3 Direct Acting Antiviral Agents Simeprevir, Odalasvir and AL-335 at Steady State in Healthy Japanese ParticipantsCompletedNCT02824315Phase 1
• Study to Investigate the Pharmacokinetics, Safety and Tolerability of Odalasvir and AL-335 in Healthy Japanese ParticipantsCompletedNCT02821858Phase 1
• Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Chinese Healthy ParticipantsCompletedNCT02816853Phase 1
• An ACDF Multi-Center Study Using ViviGen Cellular Bone MatrixCompletedNCT02814825
• Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult ParticipantsCompletedNCT02813460Phase 1
• A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer ParticipantsCompletedNCT02813408
• Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-61393215 in Healthy ParticipantsCompletedNCT02812251Phase 1
• Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple MyelomaCompletedNCT02811978Phase 3
• OneTouch Select® [Brand Name]Plus Blood Glucose Monitoring System(BGMS) Registration StudyWithdrawnNCT02810522Not applicable
• An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative ColitisActive, not recruitingNCT02808780
• Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male SubjectsCompletedNCT02791815Phase 1
• Idylla IFV-RSV Panel Clinical TestingCompletedNCT02786381
• Study to Describe the Actual Situation of Hepatitis C Treatment in BrazilCompletedNCT02773394

← Johnson & Johnson overview and focus areas